Echo's glucose monitoring device shows positive trial results

12/7/2011 | Reuters

Echo Therapeutics said its Symphony tCGM device demonstrated a high accuracy rating in monitoring blood glucose levels and reported no adverse events in a clinical trial involving 20 patients with type 1 or type 2 diabetes. According to the study, 94.4% of the more than 2,600 glucose readings gathered using the device were found to be clinically accurate.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA